Résultats de la recherche - 15 results

Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.

Infections Reproducibility of Results Sensitivity and Specificity Uterine Cervical Dysplasia Uterine Cervical Neoplasms Young adult Abstract: Clinical validation of human papillomavirus (HPV) assays according ...

Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?

Detection of Cancer Female Humans Mass Screening Papillomaviridae Papillomavirus Infections Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vaginal Smears Abstract: “Can REALQUALITY RQ- HPV screen be ...

HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions.

Uterine Cervical Neoplasms Abstract: In 2017, cervical cancer screening in the Netherlands switched from cytology to human papillomavirus (HPV) testing using the validated PCR-based cobas 4800. Women could ...

Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.

Volume 13 (2022) Keywords: BNT162 Vaccine COVID-19 Cytokines Female Humans Intercellular Signaling Peptides and Proteins Neoplasms Placenta Growth Factor vaccines Abstract: BACKGROUND: Patients with ...

Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.

Viral Biomarkers BNT162 Vaccine COVID-19 Vaccines Humans Immunity, Humoral Immunization Schedule Immunization, Secondary Immunogenicity, Vaccine Neoplasms Prospective Studies Risk Factors Time Factors ...

Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.

5 (2021) Keywords: Antineoplastic Agents BNT162 Vaccine COVID-19 COVID-19 Vaccines Humans Immunity, Humoral Neoplasms Prospective Studies RNA, Messenger SARS-CoV-2 Vaccination Abstract: BACKGROUND: Cancer ...

HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study

80 and over Alphapapillomavirus Belgium Cyclin-Dependent Kinase Inhibitor p16 DNA, Viral Female Genotype Head and Neck Neoplasms Head and neck neoplasms; Human papillomavirus; Human papillomavirus DNA ...

Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study.

One, Volume 12, Issue 10 (2017) Keywords: Carcinoma Europe Head and Neck Neoplasms Humans India Molecular Diagnostic Techniques Molecular Epidemiology Necrosis Paraffin Paraffin Embedding Pilot Projects ...

Barriers and opportunities for return-to-work of cancer survivors: time for action--rapid review and expert consultation.

Volume 5, p.35 (2016) Keywords: Age factors Antineoplastic Agents Combined Modality Therapy dépression Educational Status Fatigue Humans Income Neoplasm Staging Neoplasms pain Protective Factors Referral ...

Premature mortality in Belgium in 1993-2009: leading causes, regional disparities and 15 years change

among men and by 22% among women over a period of 15 years. Among men, circulatory diseases death rates decreased the fastest (-43.4%), followed by the neoplasms (-26.6%), the other natural causes ...

QR code

QR code for this page URL